PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
-3.65%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$342M
AUM Growth
+$342M
(-23%)
Cap. Flow
-$58.8M
Cap. Flow
% of AUM
-17.22%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
99
New
15
Increased
34
Reduced
31
Closed
18
Top Buys
| 1 |
Tenet Healthcare
THC
|
$8.53M |
| 2 |
iRhythm Technologies
IRTC
|
$6.61M |
| 3 |
Neurocrine Biosciences
NBIX
|
$5.93M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$4.87M |
| 5 |
Teleflex
TFX
|
$4.44M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$10.9M |
| 3 |
DexCom
DXCM
|
$10.3M |
| 4 |
Avantor
AVTR
|
$8.43M |
| 5 |
Danaher
DHR
|
$6.42M |
Sector Composition
| 1 | Healthcare | 96.94% |
| 2 | Industrials | 2.69% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iRhythm Technologies
IRTC
$5.46B
| $16.4M | 4.79% | 103,981 +42,001 | +68% | +$6.61M |
|
2
United Therapeutics
UTHR
$13.8B
| $13.3M | 3.89% | 74,107 -16,091 | -18% | -$2.89M |
|
3
UnitedHealth
UNH
$281B
| $12.9M | 3.78% | 25,327 -12,496 | -33% | -$6.37M |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.4M | 3.63% | 86,096 +5,301 | +7% | +$764K |
|
5
Immunic
IMUX
$80.9M
| $12.3M | 3.6% | 1,089,251 +115,068 | +12% | +$1.3M |
|
|
6
Tenet Healthcare
THC
$16.3B
| $12M | 3.5% | 139,185 +99,185 | +248% | +$8.53M |
|
7
IQVIA
IQV
$32.4B
| $11.6M | 3.39% | 50,090 -23,022 | -31% | -$5.32M |
|
8
Aclaris Therapeutics
ACRS
$209M
| $11.5M | 3.37% | 668,098 -357,424 | -35% | -$6.16M |
|
|
9
Danaher
DHR
$147B
| $10.8M | 3.17% | 36,972 -21,875 | -37% | -$6.42M |
|
10
Xenon Pharmaceuticals
XENE
$2.98B
| $9.3M | 2.72% | 304,186 -56,316 | -16% | -$1.72M |
|
|
RCM
11
DELISTED
R1 RCM Inc. Common Stock
RCM
| $9.18M | 2.69% | 342,923 +42,528 | +14% | +$1.14M |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $8.82M | 2.58% | 54,008 -3,674 | -6% | -$600K |
|
|
CTLT
13
DELISTED
CATALENT, INC.
CTLT
| $8.77M | 2.57% | 79,049 +18,110 | +30% | +$2.01M |
|
14
CVS Health
CVS
$92.8B
| $8.67M | 2.54% | 85,618 -47,716 | -36% | -$4.83M |
|
|
CDMO
15
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $8.3M | 2.43% | 407,458 +117,458 | +41% | +$2.39M |
|
16
Cooper Companies
COO
$13.4B
| $8.18M | 2.39% | 19,585 -4,130 | -17% | -$1.72M |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.76M | 2.27% | 476,978 +76,977 | +19% | +$1.25M |
|
18
AbbVie
ABBV
$372B
| $7.41M | 2.17% | 45,731 -5,991 | -12% | -$971K |
|
|
19
DexCom
DXCM
$29.5B
| $6.52M | 1.91% | 12,737 -20,169 | -61% | -$10.3M |
|
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $5.93M | 1.73% | +63,234 | New | +$5.93M |
|
21
Codexis
CDXS
$246M
| $5.53M | 1.62% | 268,144 -72,008 | -21% | -$1.48M |
|
|
22
Avantor
AVTR
$9.18B
| $5.36M | 1.57% | 158,365 -249,210 | -61% | -$8.43M |
|
23
Natera
NTRA
$23.1B
| $5.29M | 1.55% | 129,944 +5,394 | +4% | +$219K |
|
24
Arcus Biosciences
RCUS
$1.13B
| $5.28M | 1.55% | 167,321 +50,222 | +43% | +$1.59M |
|
25
Alphatec Holdings
ATEC
$2.35B
| $5.2M | 1.52% | 451,794 +216,871 | +92% | +$2.49M |
|